Loading...

Home
Stock
CTNM

CTNM News & Events

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Forecast Technical Valuation Financials Earnings Should I Buy News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

CTNM News

Moderna Inc (MRNA) Projects $1.9 Billion Revenue for 2025, Shares Surge 12.8%

Jan 13 2026Benzinga

Contineum Therapeutics Prices Upsized Offering of 7.35M Shares at $12.25, Raising $90M

Dec 12 2025Newsfilter

Contineum Therapeutics Prices Upsized Offering of 7.35M Shares at $12.25, Raising $90M

Dec 12 2025Businesswire

Contineum Therapeutics Launches $75 Million Public Offering

Dec 11 2025Newsfilter

Contineum Stock Declines Following Unsuccessful Phase 2 PIPE-307 Trial for Multiple Sclerosis Efficacy

Nov 21 2025Yahoo Finance

Contineum Therapeutics' Multiple Sclerosis Trial Falls Short, Yet Analyst Believes Other Assets Will Enhance Value

Nov 21 2025Benzinga

Lululemon Analyst Changes Stance; Check Out Thursday's Top 3 Downgrades

Sep 25 2025Benzinga

Biogen Analyst Starts Coverage Optimistically; Check Out Thursday's Top 5 Initiations

Sep 25 2025Benzinga

CTNM Events

Goldman Sachs Increases Offering Size to $90M

The deal size was increased to $90M in common stock from $75M in common stock. Goldman Sachs, Leerink, Stifel, RBC Capital and William Blair acted as joint book running managers for the offering.

Goldman Sachs and Others Act as Joint Book-Running Managers for Proposed Offering

Goldman Sachs & Co. LLC, Leerink Partners, Stifel, RBC Capital Markets and William Blair are acting as joint book-running managers for the proposed offering. Jones is acting as manager for the proposed offering.

CTNM Monitor News

No data

No data

CTNM Earnings Analysis

No Data

No Data

People Also Watch